Current Progressive Cattle digital edition

AgriLabs announces sales, marketing deal with ImmuCell

Published on 24 March 2011

Steve Schram, AgriLabs President and CEO, announced March 16 that AgriLabs has aligned with ImmuCell Corporation for the development, sales, and marketing of certain current and future products featuring ImmuCell's First Defense® bolus.

“This collaboration furthers our commitment to make available relevant and technically driven products that get newborn calves off to a strong start."  The arrangement bolsters ImmuCell's ability to reach more calves with First Defense products, and fits AgriLabs business model of collaborating with companies who can benefit from a broad reach sales and marketing organization such as AgriLabs, added Schram.

To augment its core vaccine capabilities, AgriLabs continues to expand its value to the food animal market by adding science-backed neonatal and young calf care products from innovative partners.

"First Defense is a USDA-approved product prepared from hyperimmune bovine colostrum that reduces morbidity and mortality from neonatal calf scours by providing specific neutralizing antibodies against bovine coronavirus and K99+ E. coli . The dried colostral antibodies quickly afford Immediate Immunity™, thereby reducing scours-related morbidity and mortality." explained, Dr. Joel Ehrenzweig, AgriLabs Technical Services Manager. end_mark